Synthesis and structure–activity relationship of cyclopentenone oximes as novel inhibitors of the production of tumor necrosis factor-α
摘要:
3-Alkyl-2-aryl-2-cyclopenten-1-one oxime derivatives (1) were studied as a novel class of inhibitors of tumor necrosis factor alpha (TNF-alpha) with regard to synthesis and in vitro SAR inhibition of TNF-alpha. The in vitro IC50 values of these compounds in rat and human peripheral blood mononuclear cells were at the sub-micromolar level. (C) 2014 Elsevier Ltd. All rights reserved.
2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha
申请人:Kim Yeonjoon
公开号:US20090036501A1
公开(公告)日:2009-02-05
2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-α or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-α or PDE4.
2-CYCLOPENTEN-1-ONE OXIME DERIVATIVES INHIBITING PRODUCTION OF TNF-ALPHA
申请人:Amorepacific Corporation
公开号:EP1841729A1
公开(公告)日:2007-10-10
US8013187B2
申请人:——
公开号:US8013187B2
公开(公告)日:2011-09-06
[EN] 2-CYCLOPENTEN-1-ONE OXIME DERIVATIVES INHIBITING PRODUCTION OF TNF-ALPHA<br/>[FR] DERIVES DE 2-CYCLOPENTENE-1-ONE OXIME INHIBANT LA PRODUCTION DE TNF-ALPHA
申请人:AMOREPACIFIC CORP
公开号:WO2006059867A1
公开(公告)日:2006-06-08
[EN] 2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-a or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-a or PDE4. [FR] L'invention concerne des dérivés de 2-cyclopentène-1-one oxime représentés par la Formule (I), ou des sels pharmaceutiquement acceptables de ceux-ci, inhibant la production de TNF-a ou de PDE4. Les dérivés selon l'invention présentent un effet thérapeutique contre les troubles inflammatoires ou immunologiques induits par TNF-a ou PDE4.